Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial

BACKGROUND: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure. Although angiotensin II receptor blockers (ARBs) can be used to attenuate proteinuria in DN patients, their efficacy remains limited. This clinical trial aimed to evaluate the efficacy of Tripterygium wilfordi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ge, Yongchun, Xie, Honglang, Li, Shijun, Jin, Bo, Hou, Jinhua, Zhang, Haitao, Shi, Mingjun, Liu, Zhihong
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670993/
https://ncbi.nlm.nih.gov/pubmed/23725518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-134
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items